Skip to main content

Claro Advisors Inc.

Position in NVS — Novartis AG

CIK 1764386 BOSTON, MA

Position in NVS

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$370,799
+$20,849 QoQ
Shares Held
2,366
+3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,022
of 1,603 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Claro Advisors Inc. holds $23,719,798 across 11 Drug Manufacturers - General names. NVS ranks #10 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $370,799 2,366
2026-03-31 $349,950 2,291
2025-12-31 $288,837 2,095
2025-09-30 $273,920 2,136
2025-06-30 $267,432 2,210
2025-03-31 $236,226 2,119
2024-12-31 $384,763 3,954
2024-09-30 $533,462 4,638
2022-09-30 $356,866 4,695
2022-06-30 $396,868 4,695
2022-03-31 $251,579 2,867
2021-12-31 $250,776 2,867
2021-09-30 $240,760 2,944
2021-06-30 $246,439 2,701
2021-03-31 $230,966 2,702
2020-12-31 $237,208 2,512
2020-09-30 $276,532 3,180
2020-06-30 $268,395 3,073
2020-03-31 $228,551 2,772